TY - JOUR
T1 - Anti-inflammatory effects of vagus nerve stimulation in pediatric patients with epilepsy
AU - Kaur, Supender
AU - Selden, Nathan R.
AU - Aballay, Alejandro
N1 - Funding Information:
This work was supported by NIH grants AI156900 and GM070977 (to AA). Acknowledgments
Publisher Copyright:
Copyright © 2023 Kaur, Selden and Aballay.
PY - 2023
Y1 - 2023
N2 - Introduction: The neural control of the immune system by the nervous system is critical to maintaining immune homeostasis, whose disruption may be an underlying cause of several diseases, including cancer, multiple sclerosis, rheumatoid arthritis, and Alzheimer’s disease. Methods: Here we studied the role of vagus nerve stimulation (VNS) on gene expression in peripheral blood mononuclear cells (PBMCs). Vagus nerve stimulation is widely used as an alternative treatment for drug-resistant epilepsy. Thus, we studied the impact that VNS treatment has on PBMCs isolated from a cohort of existing patients with medically refractory epilepsy. A comparison of genome-wide changes in gene expression was made between the epilepsy patients treated and non-treated with vagus nerve stimulation. Results: The analysis showed downregulation of genes related to stress, inflammatory response, and immunity, suggesting an anti-inflammatory effect of VNS in epilepsy patients. VNS also resulted in the downregulation of the insulin catabolic process, which may reduce circulating blood glucose. Discussion: These results provide a potential molecular explanation for the beneficial role of the ketogenic diet, which also controls blood glucose, in treating refractory epilepsy. The findings indicate that direct VNS might be a useful therapeutic alternative to treat chronic inflammatory conditions.
AB - Introduction: The neural control of the immune system by the nervous system is critical to maintaining immune homeostasis, whose disruption may be an underlying cause of several diseases, including cancer, multiple sclerosis, rheumatoid arthritis, and Alzheimer’s disease. Methods: Here we studied the role of vagus nerve stimulation (VNS) on gene expression in peripheral blood mononuclear cells (PBMCs). Vagus nerve stimulation is widely used as an alternative treatment for drug-resistant epilepsy. Thus, we studied the impact that VNS treatment has on PBMCs isolated from a cohort of existing patients with medically refractory epilepsy. A comparison of genome-wide changes in gene expression was made between the epilepsy patients treated and non-treated with vagus nerve stimulation. Results: The analysis showed downregulation of genes related to stress, inflammatory response, and immunity, suggesting an anti-inflammatory effect of VNS in epilepsy patients. VNS also resulted in the downregulation of the insulin catabolic process, which may reduce circulating blood glucose. Discussion: These results provide a potential molecular explanation for the beneficial role of the ketogenic diet, which also controls blood glucose, in treating refractory epilepsy. The findings indicate that direct VNS might be a useful therapeutic alternative to treat chronic inflammatory conditions.
KW - blood glucose
KW - cytokines
KW - insulin
KW - neuroimmune
KW - peripheral blood monocytes cells
KW - seizure
KW - tumor necrosis factor
KW - vagus nerve stimulation
UR - http://www.scopus.com/inward/record.url?scp=85149053381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149053381&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2023.1093574
DO - 10.3389/fimmu.2023.1093574
M3 - Article
C2 - 36845140
AN - SCOPUS:85149053381
SN - 1664-3224
VL - 14
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1093574
ER -